Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Arterial, venous and other vascular risk factors in multiple sclerosis.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis.
Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation.
Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Advances in Antioxidative Therapy of Multiple Sclerosis.
Deimination restores inner retinal visual function in murine demyelinating disease.
Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
In vivo detection of experimental optic neuritis by pupillometry.
Multiple sclerosis: Natalizumab reduces cortical pathology in relapsing-remitting multiple sclerosis.
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis.
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications.
Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report.
Introducing demographic corrections for the 10/36 Spatial Recall Test.
Imaging new lesions: Enhancing our understanding of multiple sclerosis pathogenesis.
Pages
« first
‹ previous
…
245
246
247
248
249
250
251
252
253
…
next ›
last »